|
Commission Regulation
(EC) No 2086/2004 of 19 November 2004 amended
by Regulation (EC) No 1725/2003,
Regulation (EC) No 1751/2005,
Regulation (EC) No 1864/2005,
Regulation (EC) No 1910/2005
and Regulation (EC) No 2106/2005
Content |
|
- |
Impairment and Uncollectibility of Financial Assets
58. An entity
shall assess at each balance sheet date whether there is any
objective evidence that a financial asset or group of
financial assets is impaired. If any such evidence exists,
the entity shall apply paragraph 63 (for financial assets
carried at amortised cost), paragraph 66 (for financial
assets carried at cost) or paragraph 67 (for
available-for-sale financial assets) to determine the amount
of any impairment loss.
59. A financial
asset or a group of financial assets is impaired and
impairment losses are incurred if, and only if, there is
objective evidence of impairment as a result of one or more
events that occurred after the initial recognition of the
asset (a ‘loss event’) and that loss event (or events) has
an impact on the estimated future cash flows of the
financial asset or group of financial assets that can be
reliably estimated. It may not be possible to identify a
single, discrete event that caused the impairment. Rather
the combined effect of several events may have caused the
impairment. Losses expected as a result of future events, no
matter how likely, are not recognised. Objective evidence
that a financial asset or group of assets is impaired
includes observable data that comes to the attention of the
holder of the asset about the following loss events:
(a)
significant financial difficulty of the issuer or
obligor;
(b) a breach
of contract, such as a default or delinquency in
interest or principal payments;
(c) the lender,
for economic or legal reasons relating to the borrower’s
financial difficulty, granting to the borrower a
concession that the lender would not otherwise consider;
(d) it
becoming probable that the borrower will enter
bankruptcy or other financial reorganisation;
(e) the
disappearance of an active market for that financial
asset because of financial difficulties;
or
(f) observable
data indicating that there is a measurable decrease in
the estimated future cash flows from a group of
financial assets since the initial recognition of those
assets, although the decrease cannot yet be identified
with the individual financial assets in the group,
including:
(i)
adverse changes in the payment status of borrowers
in the group (eg an increased number of delayed
payments or an increased number of credit card
borrowers who have reached their credit limit and
are paying the minimum monthly amount);
or
(ii)
national or local economic conditions that correlate
with defaults on the assets in the group (eg an
increase in the unemployment rate in the
geographical area of the borrowers, a decrease in
property prices for mortgages in the relevant area,
a decrease in oil prices for loan assets to oil
producers, or adverse changes in industry conditions
that affect the borrowers in the group).
60. The
disappearance of an active market because an entity’s
financial instruments are no longer publicly traded is not
evidence of impairment. A downgrade of an entity’s credit
rating is not, of itself, evidence of impairment, although
it may be evidence of impairment when considered with other
available information. A decline in the fair value of a
financial asset below its cost or amortised cost is not
necessarily evidence of impairment (for example, a decline
in the fair value of an investment in a debt instrument that
results from an increase in the risk-free interest rate).
61. In addition to
the types of events in paragraph 59, objective evidence of
impairment for an investment in an equity
instrument includes information about significant changes
with an adverse effect that have taken place in the
technological,
market, economic or legal environment in which the issuer
operates, and indicates that the cost of the investment
in the equity instrument may not be recovered. A significant
or prolonged decline in the fair value of an investment
in an equity instrument below its cost is also objective
evidence of impairment.
62. In some cases the observable data required to estimate
the amount of an impairment loss on a financial asset may be
limited or no longer fully relevant to current circumstances.
For example, this may be the case when a borrower is in
financial difficulties and there are few available
historical data relating to similar borrowers. In such cases,
an entity uses
its experienced judgement to estimate the amount of any
impairment loss. Similarly an entity uses its experienced
judgement
to adjust observable data for a group of financial assets to
reflect current circumstances (see paragraph AG89). The
use of reasonable estimates is an essential part of the
preparation of financial statements and does not undermine
their
reliability.
Financial Assets Carried at Armortised Cost
63. If there
is objective evidence that an impairment loss on loans and
receivables or held-to-maturity investments carried at
amortised cost has been incurred, the amount of the loss is
measured as the difference between the asset’s carrying
amount and the present value of estimated future cash flows
(excluding future credit losses that have not been incurred)
discounted at the financial asset’s original effective
interest rate (ie the effective interest rate computed at
initial recognition). The carrying amount of the asset shall
be reduced either directly or through use of an allowance
account. The amount of the loss shall be recognised in
profit or loss.
64. An entity
first assesses whether objective evidence of impairment
exists individually for financial assets that are
individually significant, and individually or collectively
for financial assets that are not individually significant (see
paragraph 59). If an entity determines that no objective
evidence of impairment exists for an individually assessed
financial asset, whether significant or not, it includes the
asset in a group of financial assets with similar credit
risk characteristics and collectively assesses them for
impairment. Assets that are individually assessed for
impairment and for which an impairment loss is or continues
to be recognised are not included in a collective assessment
of impairment.
65. If, in a
subsequent period, the amount of the impairment loss
decreases and the decrease can be related objectively to an
event occurring after the impairment was recognised (such as
an improvement in the debtor’s credit rating), the
previously recognised impairment loss shall be reversed
either directly or by adjusting an allowance account. The
reversal shall not result in a carrying amount of the
financial asset that exceeds what the amortised cost would
have been had the impairment not been recognised at the date
the impairment is reversed. The amount of the reversal shall
be recognised in profit or loss.
Financial
Assets Carried at Cost
66. If there
is objective evidence that an impairment loss has been
incurred on an unquoted equity instrument that is not
carried at fair value because its fair value cannot be
reliably measured, or on a derivative asset that is linked
to and must be settled by delivery of such an unquoted
equity instrument, the amount of the impairment loss is
measured as the difference between the carrying amount of
the financial asset and the present value of estimated
future cash flows discounted at the current market rate of
return for a similar financial asset (see paragraph 46(c)
and Appendix A paragraphs AG80 and AG81). Such impairment
losses shall not be reversed.
Available - for - Sale Financial Assets
67. When a
decline in the fair value of an available-for-sale financial
asset has been recognised directly in equity and there is
objective evidence that the asset is impaired (see paragraph
59), the cumulative loss that had been recognised directly
in equity shall be removed from equity and recognised in
profit or loss even though the financial asset has not been
derecognised.
68. The
amount of the cumulative loss that is removed from equity
and recognised in profit or loss under paragraph 67 shall be
the difference between the acquisition cost (net of any
principal repayment and amortisation) and current fair value,
less any impairment loss on that financial asset previously
recognised in profit or loss.
69.
Impairment losses recognised in profit or loss for an
investment in an equity instrument classified as available
for sale shall not be reversed through profit or loss.
70. If, in a
subsequent period, the fair value of a debt instrument
classified as available for sale increases and the increase
can be objectively related to an event occurring after the
impairment loss was recognised in profit or loss, the
impairment loss shall be reversed, with the amount of the
reversal recognised in profit or loss.
Previous |
Index |
Next
|